Related references
Note: Only part of the references are listed.ENTPD1/CD39 is a promising therapeutic target in oncology
J. Bastid et al.
ONCOGENE (2013)
Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity
Gabriella Pietra et al.
CANCER RESEARCH (2012)
The T-cell Receptor Repertoire of Tumor-Infiltrating Regulatory T Lymphocytes Is Skewed Toward Public Sequences
Alexander Sainz-Perez et al.
CANCER RESEARCH (2012)
The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature
Ronald J. deLeeuw et al.
CLINICAL CANCER RESEARCH (2012)
Program death-1 regulates peripheral T cell tolerance via an anergy-independent mechanism
Guilin Qiao et al.
CLINICAL IMMUNOLOGY (2012)
Phenotypic and functional characteristics of CD4+CD39+FOXP3+ and CD4+CD39+FOXP3neg T-cell subsets in cancer patients
Patrick J. Schuler et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Immune checkpoints in central nervous system autoimmunity
Nicole Joller et al.
IMMUNOLOGICAL REVIEWS (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
CD39/Adenosine Pathway Is Involved in AIDS Progression
Maria Nikolova et al.
PLOS PATHOGENS (2011)
The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses
Lucy S. K. Walker et al.
NATURE REVIEWS IMMUNOLOGY (2011)
The PD-1 pathway in tolerance and autoimmunity
Loise M. Francisco et al.
IMMUNOLOGICAL REVIEWS (2010)
Generation and Accumulation of Immunosuppressive Adenosine by Human CD4+CD25highFOXP3+ Regulatory T Cells
Magis Mandapathil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
LAG-3 Expression Defines a Subset of CD4+CD25highFoxp3+ Regulatory T Cells That Are Expanded at Tumor Sites
Chiara Camisaschi et al.
JOURNAL OF IMMUNOLOGY (2010)
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Loise M. Francisco et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Maturation Pathways of Dendritic Cells Determine TAP1 and TAP2 Levels and Cross-presenting Function
Andres Lopez-Abaitero et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways
Brian T. Fife et al.
IMMUNOLOGICAL REVIEWS (2008)
Preferential costimulation by CD80 results in IL-10-dependent TGF-β1+-adaptive regulatory T cell generation
Nicolas Perez et al.
JOURNAL OF IMMUNOLOGY (2008)
Acquisition of suppressive function by activated human CD4+CD25- T cells is associated with the expression of CTLA-4 not FoxP3
Yong Zheng et al.
JOURNAL OF IMMUNOLOGY (2008)
CTLA-4 control over Foxp3+ regulatory T cell function
Kajsa Wing et al.
SCIENCE (2008)
The frequency and suppressor function of CD4+CD25high Foxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck
Laura Strauss et al.
CLINICAL CANCER RESEARCH (2007)
A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β- and retinoic acid-dependent mechanism
Janine L. Coombes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid
Cheng-Ming Sun et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinorna and its premalignant lesions
Nobuyoshi Hiraoka et al.
CLINICAL CANCER RESEARCH (2006)
TGF-β-mediated suppression by CD4+CD25+ T cells is facilitated by CTLA-4 signaling
Takatoku Oida et al.
JOURNAL OF IMMUNOLOGY (2006)
Characteristics of CD4+ CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer
C Schaefer et al.
BRITISH JOURNAL OF CANCER (2005)
Distinct robes of CTLA-4 and TGF-β in CD4+CD25+ regulatory T cell function
QZ Tang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Share Paper
